Abstract:Objective:To explore the effect of astragalus polysaccharide (APS) on fatty acid metabolism and lipid toxicity in diabetic cardiomyopathy.Methods:The 5 weeks old male type 2 diabetes model db/db mice were divided into astragalus polysaccharides group,metformin group and diabetic group,according to the random number table method.Each group had 8 rats,which were given APS 2000 mg/kg,metformin 2000 mg/kg and an equal amount of saline through nasogastric tube for 12 weeks respectively.Eight same-age C57BL/6J mice were set as normal group and fed with the same amount of normal saline.Cardiac function was examined by echocardiography in each group.Bligh-Dyer and ESIMS were used to detect myocardial triglyceride deposition.Micro-positron emission tomography was used to detect myocardial fatty acid uptake and index of oxidative metabolism.Western blot was used to detect the protein expression level of key enzymes involved in the metabolism of fatty acids.Results:(1) The LVEDD and LVESD were increased significantly,while the LV fractional shortening (FS) were decreased significantly in diabetic group compared with those in normal group (all P＜0.05).The above indexes of APS group were significantly improved compared with those of diabetic group (all P＜0.05).There was no significant difference in above indexes between metformin group and diabetic group.(2) Compared with the normal group,the fatty acid uptake rate,the free fatty acid oxidation rate,the triglyceride content and the triglyceride subtypes in diabetic group were significantly increased (all P＜0.05) The above indexes in APS group were significantly lower than those in diabetic group (all P＜0.05).There was no significant difference in above indexes between the metformin group and diabetic group.(3) Compared with normal group,the protein expression levels of PPARα,M-CPT 1 and ACO in myocardium were significantly increased in diabetic group (all P＜0.05).The expression of these proteins was significantly lower in APS group than those in diabetic group (all P＜0.05).There was no significant difference in protein expression between the metformin group and diabetic group.Conclusions:APS can improve fatty acid metabolism in diabetic myocardium,including improving cardiac function,decreasing fatty acid uptake and utilization rate,free fatty acid oxidation rate and triglyceride content in the myocardium of diabetic mice,and controlling the fatty acid metabolism related proteins in the myocardium of diabetic mice at normal levels.

Astraglus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice

Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet–Induced Metabolic Disorders

Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease

Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota

Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice

Astragalus polysaccharide alleviates alcoholic-induced hepatic fibrosis by inhibiting polymerase I and transcript release factor and the TLR4/JNK/NF-κB/MyD88 pathway

Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice

Therapy With Astragalus Polysaccharides Rescues Lipotoxic Cardiomyopathy In Mhc-Ppar Alpha Mice

Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice

Mechanism of astragalus polysaccharide therapy in improving myocardial lipid toxicity in db/db diabetic obese mice

Astragalus polysaccharide prevents heart failure-induced cachexia by alleviating excessive adipose expenditure in white and brown adipose tissue

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora

Effects of APS Activates Hepatic Insulin Signaling in HFD-induced IR Mice.

The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism

Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats

Astragalus polysaccharide liposome nanoparticles mediate fatty acid translocase (FAT)/CD36 to improve fatty acid metabolism and regulate glucocorticoid receptor levels in diabetic cardiomyopathy

Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha

Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice

Astragalus polysaccharide (APS) improves the immune function in diet-induced obese (DIO) mice

Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE−/− Mice

Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease